Avestar Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $268K | Sell |
510
-164
| -24% | -$86.1K | 0.02% | 363 |
|
|
2025
Q1 | $427K | Sell |
674
-113
| -14% | -$71.7K | 0.04% | 271 |
|
|
2024
Q4 | $561K | Buy |
787
+64
| +9% | +$45.6K | 0.05% | 237 |
|
|
2024
Q3 | $760K | Buy |
723
+52
| +8% | +$54.7K | 0.08% | 181 |
|
|
2024
Q2 | $705K | Sell |
671
-17
| -2% | -$17.9K | 0.07% | 177 |
|
|
2024
Q1 | $662K | Buy |
688
+323
| +88% | +$311K | 0.07% | 179 |
|
|
2023
Q4 | $321K | Buy |
+365
| New | +$321K | 0.04% | 261 |
|
|
2019
Q3 | – | Sell |
-78
| Closed | -$21K | – | 688 |
|
|
2019
Q2 | $21K | Sell |
78
-7
| -8% | -$1.89K | 0.01% | 388 |
|
|
2019
Q1 | $33K | Sell |
85
-209
| -71% | -$81.1K | 0.02% | 329 |
|
|
2018
Q4 | $87K | Sell |
294
-54
| -16% | -$16K | 0.06% | 197 |
|
|
2018
Q3 | $122K | Buy |
348
+57
| +20% | +$20K | 0.07% | 175 |
|
|
2018
Q2 | $85K | Buy |
291
+26
| +10% | +$7.6K | 0.05% | 217 |
|
|
2018
Q1 | $77K | Buy |
265
+92
| +53% | +$26.7K | 0.05% | 204 |
|
|
2017
Q4 | $45K | Buy |
+173
| New | +$45K | 0.03% | 261 |
|